Epigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting)

Phytother Res. 2021 Jul;35(7):3649-3664. doi: 10.1002/ptr.7059. Epub 2021 Feb 22.

Abstract

Epigenetic alterations are one of the main factors that disrupt the expression of genes and consequently, they have an important role in the carcinogenicity and the progression of different cancers. Cancer stem cells (CSCs) are accountable for the recurrence, metastasis, and therapeutic failure of cancer. The noticeable and specific pathways in CSCs can be organized by epigenetic mechanisms such as DNA methylation, chromatin remodeling, regulatory RNAs, among others. Since epigenetics modifications can be changed and reversed, it is a possible tool for cancer control and treatment. Epigenetic therapies against CSCs are emerging as a very new strategy with a good future expectation to treat cancer patients. Phenolic compounds are a vast group of substances with anticarcinogenic functions, antiinflammatory, and antioxidative activities. It seems these characteristics are related to neutralizing CSCs development, their microenvironment, and metabolism through epigenetic mechanisms. In the current work, the types of epigenetic changes known in these cells are introduced. In addition, some studies about the use of polyphenols acting through a variety of epigenetic mechanisms to counteract these cells will be reviewed. The reported results seem to indicate that the use of these phenolic compounds may be useful for CSCs defeat.

Keywords: cancer stem cells (CSCs); epigenetics; polyphenols.

Publication types

  • Review

MeSH terms

  • DNA Methylation
  • Epigenesis, Genetic*
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Neoplastic Stem Cells / drug effects*
  • Polyphenols* / pharmacology
  • Tumor Microenvironment

Substances

  • Polyphenols